Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Occurrence of HCC and Possible Differences in Its Course Depending on DAA Treatment

NCT05376943 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.

NCT NCT05376943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05376943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Occurrence of HCC and Possible Differences in Its Course Depending on DAA Treatment
Lead sponsor
Medical University of Warsaw
Phase
Observational
Overall status
Unknown status
Start date
May 10, 2022
Completion date
December 31, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, hepatocellular, drug effect, drug side effect, hepatitis c virus infection, response to therapy of, hepatitis c, chronic, liver cirrhosis